Study links higher-potency cannabis use in youth to increased risk of psychotic experiences

FHS
May 14, 2024
6:25 pm

Young individuals consuming higher-potency cannabis, such as skunk, between ages 16 and 18, are twice as likely to have psychotic experiences from age 19 to 24 compared to those using lower-potency cannabis.

Harnessing brain proteins for enhanced diabetes and weight-loss drugs

A network of proteins found in the central nervous system could be harnessed to increase the effectiveness and reduce the side effects of popular diabetes

July 16, 2024

Arrayjet’s ArrayPlex platform selected by Immunome for use in its discovery of targeted cancer therapies

Immunome signs deal to use Arrayjet platform in its in-house screening operations.

March 18, 2024

Risk Adjusted Net Present Value: What is the current valuation of Zai Lab’s (Trospium chloride + Xanomeline)

The revenue for (Trospium chloride + Xanomeline) is expected to reach an annual total of $761 mn by 2033 globally based off GlobalData’s Expiry Model.

May 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.